EHS
EHS

Effect of Ribavirin in Anti–HCV Genotype 3 Therapy in Patients with Cirrhosis

Adding ribavirin to sofosbuvir/velpatasvir did not result in superior efficacy but seems to overcome baseline virologic resistance.
EHS
Back to top button